explore -WSS

explore

author：Wikipedia 2025-09-27 21:27:55 - browse：3

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Biden targets hefty hospital 'facility fees' that often surprise patients

WSS

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Elizabeth Holmes banned from government health programs

Eli Lilly, Pfizer, and others want in on the online prescription market

My yearlong odyssey to get my son’s ADHD medication covered

Research misconduct: Proposed new rules face resistance

NIH director takes cautious approach to Biden drug pricing priority

Wikipedia

explore

focus

Apple is now the first public company to be valued at $3 trillion

How digital therapeutics firms are pivoting after Pear's bankruptcy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New brain studies show LSD's effects on the brain in full color

Activists slam private health insurers over coverage restrictions

Create a giant ice tray with this foil pan hack to keep food cold this summer

In Memoriam: Notable people who died in 2023

Biotech venture capitalists face new demands from investors

How one medical school became remarkably diverse

Pandemic and All Hazards Preparedness Act needs lean update

focus

Test for long Covid? Researchers find new clue in blood samples

Dewpoint Therapeutics lays off staff after losing partnerships

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Biotech venture capitalists face new demands from investors

The aspartame in Diet Coke probably isn’t giving you cancer

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

hotspot

leisure time

leisure time

hotspot